Ramipril 5 mg Capsules bulk supplier for pharma manufacturers

Ramipril 5 mg Capsules 1.25 mg, 2.5 mg, 5 mg, 10 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules/Tablets

Available Strengths: 1.25 mg, 2.5 mg, 5 mg, 10 mg

Reference Brands: Altace (US), Tritace (EU/UK), Cardace (India)

Ramipril is an ACE inhibitor that blocks the formation of angiotensin II, leading to vasodilation, reduced blood pressure, and decreased workload on the heart. It effectively prevents strokes, heart attacks, and heart failure progression, improving cardiovascular health, reducing symptoms, and supporting long-term management of hypertension and heart disease.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ramipril 5 mg Capsules? List it or send an offer →

Product Description:

Ramipril capsules and tablets, marketed as Altace in the US and as generic Ramipril across the EU, are approved for hypertension, heart failure, and cardiovascular risk reduction. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing standards. Ensuring compliance supports timely approval, safe use, and worldwide availability of ramipril, enabling effective blood pressure and cardiovascular management globally.

Ramipril 5 mg Capsules — third party manufacturing & bulk supply

Ramipril 5 mg Capsules 1.25 mg, 2.5 mg, 5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ramipril 5 mg Capsules is supplied as Capsules/Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ramipril 5 mg Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ramipril 5 mg Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ramipril 5 mg is used to treat high blood pressure (hypertension), reduce the risk of heart attack, stroke, and cardiovascular mortality in high-risk patients, and manage heart failure. It also helps protect kidney function in patients with diabetes or other kidney-related conditions.

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor that works by blocking the conversion of angiotensin I to angiotensin II, a substance that narrows blood vessels. This leads to relaxed blood vessels, lower blood pressure, and reduced strain on the heart.

The primary trade name is Altace, along with various generic brands globally.

Ramipril was originally developed and marketed by AstraZeneca and is now produced by multiple pharmaceutical companies worldwide as a generic medicine.

The generic name is Ramipril.

Brand names include Altace and various regional generic brands.

Ramipril is manufactured globally, including in the USA, Europe, India, and other regions, by several pharmaceutical companies under approved regulatory standards.